A cyclic peptide retards the proliferation of DU145 prostate cancer cells in vitro and in vivo through inhibition of FGFR2.

导出 LinkOut

翻译打印收藏纠错

作者： Yibo,Zhang ^[1] ; Man,Ouyang ^[1] ; Hailong,Wang ^[1] ; Bihui,Zhang ^[1] ; Wenhua,Guang ^[1] ; Ruiwu,Liu ^[2] ; Xiaocen,Li ^[2] ; Tsung-Chieh,Shih ^[2] ; Zhixin,Li ^[1] ; Jieqiong,Cao ^[1] ; Qiling,Meng ^[1] ; Zijian,Su ^[1] ; Jinshao,Ye ^[3] ; Feng,Liu ^[4] ; An,Hong ^[1] ; Xiaojia,Chen ^[1]

作者单位： Department of Cell Biology, College of Life Science and Technology, Jinan University National Engineering Research Center of Genetic Medicine Guangdong Provincial Key Laboratory of Bioengineering Medicine Guangdong Provincial Biotechnology Drug & Engineering Technology Research Center Jinan University Guangzhou China. ^[1] Department of Biochemistry and Molecular Medicine University of California Davis Sacramento California. ^[2] Guangdong Key Laboratory of Environmental Pollution and Health School of Environment Jinan University Guangzhou China. ^[3] China Nuclear Power Technology Research Institute Co Ltd Shenzhen China. ^[4]

关键词 cancer therapy cyclic peptide fibroblast growth factor receptor 2 (FGFR2)peptide drug

DOI 10.1002/mco2.48

PMID 34766128

发布时间 2021-12-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

MedComm

2020年1卷3期

362-375页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

A cyclic peptide retards the proliferation of DU145 prostate cancer cells in vitro and in vivo through inhibition of FGFR2.

MedComm

相似文献

MedComm

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A cyclic peptide retards the proliferation of DU145 prostate cancer cells in vitro and in vivo through inhibition of FGFR2.

MedComm

相似文献

MedComm

相关期刊

检索历史清除